삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

병리과 최윤라 교수

진료분야
분자병리, 골연부조직병리, 유방병리
진료일정 04 月
날짜
월
01
화
02
수
03
목
04
금
05
토
06
일
07
월
08
화
09
수
10
목
11
금
12
토
13
일
14
월
15
화
16
수
17
목
18
금
19
토
20
일
21
월
22
화
23
수
24
목
25
금
26
토
27
일
28
월
29
화
30
오전
오후
진료일정 05 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2003.02 서울대학교 의과대학원 의학과 박사
2001.02 서울대학교 의과대학원 의학과 석사
1996.02 서울대학교 의과대학 의학사

경력

경력
2008.03 ~현재 성균관대학교 의과대학 병리학교실 부교수
2003.08 ~현재 삼성서울병원 병리과 전문의
2006.03 ~ 2007.12 미국 스탠포드 대학교 연구원
2005.03 ~ 2007.02 삼성서울병원 병리과 임상조교수
2003.08 ~ 2005.02 삼성서울병원 병리과 전임의
2002.03 ~ 2003.07 서울대학교 의과대학 연구원
2001.03 ~ 2002.02 서울대학교병원 병리과 전임의
2001.02 병리과 전문의 자격 취득
1997.03 ~ 2001.02 삼성서울병원 병리과 레지던트
1996.03 ~ 1997.02 서울대학교병원 인턴

학회활동

학회활동
2006.05 ~ 현재 한국유방암학회 평생회원
2006.02 ~ 현재 American Association for Cancer Research 회원
2004.02 ~ 현재 United States and Canadian Academy of Pathology 회원
2001.02 ~ 현재 대한병리학회 평생회원
논문
  • ECLINICALMEDICINE 2024 10.1016/j.eclinm.2024.102478 Role of invasive mediastinal nodal staging in survival outcomes of patients with non-small cell lung cancer and without radiologic lymph node metastasis: a retrospective cohort study Kim, HK; Jeon, YJ; Um, SW; Shin, SH; Jeong, BH; Lee, K; Kim, H; Lee, HY; Kim, TJ; Lee, KS; Choi, YL; Han, JH; Ahn, YC; Pyo, H; Noh, JM; Choi, JY; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Hwang, SS; Kim, J
    View PubMed
  • J IMMUNOTHER CANCER 2024 10.1136/jitc-2023-008339 Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types Shen, JN; Choi, YL; Lee, T; Kim, H; Chae, YK; Dulken, B; Bogdan, S; Huang, M; Fisher, GA; Park, S; Lee, SH; Hwang, JE; Chung, JH; Kim, L; Song, H; Pereira, S; Shin, S; Lim, Y; Ahn, CH; Kim, S; Oum, C; Kim, S; Park, G; Song, S; Jung, W; Kim, S; Bang, YJ; Mok, TSK; Ali, SM; Ock, CY
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.408 Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology-Based EGFR Mutation Assay in Patients with Operable Non-Small Cell Lung Cancer Park, IH; Son, DS; Choi, YL; Choi, JH; Park, JE; Jeon, YJ; Cho, MS; Kim, HK; Choi, YS; Shim, YM; Kang, JH; Park, S; Lee, J; Kim, SH; Lee, BC; Kim, J
    View PubMed
  • BREAST CANCER RES 2024 10.1186/s13058-024-01768-y c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer Park, J; Chang, ES; Kim, JY; Chelakkot, C; Sung, M; Song, JY; Jung, K; Lee, JH; Choi, JY; Kim, NY; Lee, H; Kang, MR; Kwon, MJ; Shin, YK; Park, YH; Choi, YL
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.844 Trends and Clinical Characteristics of Next-Generation Sequencing-Based Genetic Panel Tests: An Analysis of Korean Nationwide Claims Data Jang, M; Pak, HY; Heo, JY; Lim, H; Choi, YL; Shim, HS; Kim, EK
    View PubMed
  • HISTOPATHOLOGY 2024 10.1111/his.15146 PD-L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading system Hwang, S; Hong, TH; Kim, HK; Cho, J; Lee, G; Choi, S; Park, S; Lee, SH; Lee, Y; Jeon, YJ; Lee, J; Park, SY; Cho, JH; Choi, YS; Kim, J; Zo, JI; Shim, YM; Choi, YL
    View PubMed
  • J KOREAN MED SCI 2023 10.3346/jkms.2023.38.e348 Clinical Course of Patients With Mediastinal Lymph Node Tuberculosis and Risk Factors for Paradoxical Responses Choe, J; Han, AR; Shin, SH; Lee, KYJ; Um, SW; Kim, H; Kim, TY; Huh, HJ; Choi, YL; Han, JH; Jeong, BH
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-14373-8 Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread Yoon, DW; Hwang, S; Hong, TH; Choi, YL; Kim, HK; Choi, YS; Kim, J; Shim, YM; Cho, JH
    View PubMed
  • J THORAC ONCOL 2023 10.1016/j.jtho.2023.05.027 Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer Jung, HA; Ku, BM; Kim, YJ; Park, S; Sun, JM; Lee, SH; Ahn, JS; Cho, JH; Kim, HK; Choi, YS; Choi, YL; Shin, SH; Jeong, BH; Um, SW; Kim, H; Kim, K; Ahn, MJ; Kim, J
    View PubMed
  • CANCERS 2023 10.3390/cancers15174380 Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery Lee, H; Choi, YL; Kim, HK; Choi, YS; Kim, H; Ahn, MJ; Pyo, HR; Choi, JY
    View PubMed
  • J THORAC ONCOL 2023 10.1016/j.jtho.2023.05.023 Comment on Leveraging NGS Data to Refine Immunotherapy Response Prediction in NSCLC: PD-L1 Copy Number, Tumor Mutation Burden, and Beyond Hong, TH; Bang, YH; Joe, C; Choi, YL; Lee, SH
    View PubMed
  • GENOME MED 2023 10.1186/s13073-023-01201-7 Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer Park, YH; Im, SA; Park, K; Wen, J; Lee, KH; Choi, YL; Lee, WC; Min, A; Bonato, V; Park, S; Ram, S; Lee, DW; Kim, JY; Lee, SK; Lee, WW; Lee, J; Kim, M; Kim, HS; Weinrich, SL; Ryu, HS; Kim, TY; Dann, S; Kim, YJ; Fernandez, DR; Koh, J; Wang, SG; Park, SY; Deng, SB; Powell, E; Ravi, RK; Bienkowska, J; Rejto, PA; Park, WY; Kan, ZY
    View PubMed
  • J THORAC ONCOL 2023 10.1016/j.jtho.2023.03.024 Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced NSCLC Hong, TH; Bang, YH; Joe, CY; Hwang, S; Lee, B; Lee, N; Park, S; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Choi, YL; Lee, SH
    View PubMed
  • MODERN PATHOL 2023 10.1016/j.modpat.2023.100184 Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance Hwang, S; Hong, TH; Kim, HK; Choi, YS; Zo, JI; Shim, YM; Han, J; Ahn, YC; Pyo, H; Noh, JM; Lee, HY; Kim, HJ; Park, S; Ahn, MJ; Park, K; Lee, SH; Choi, YL; Kim, J
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.251 Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response Hong, JY; Cho, HJ; Yun, KH; Lee, YH; Kim, SH; Baek, W; Kim, SK; Lee, Y; Choi, YL; Kwon, M; Kim, HS; Lee, J
    View PubMed
  • MODERN PATHOL 2023 10.1016/j.modpat.2023.100180 NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas Lee, SE; Lee, MS; Bang, H; Kim, MY; Choi, YL; Oh, YL
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.910 Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma Lee, MS; An, S; Song, JY; Sung, M; Jung, K; Chang, ES; Choi, J; Oh, DY; Jeon, YK; Yang, H; Lakshmi, C; Park, S; Han, J; Lee, SH; Choi, YL
    View PubMed
  • JAMA NETW OPEN 2023 10.1001/jamanetworkopen.2023.2002 Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020 Chi, SA; Yu, H; Choi, YL; Park, S; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Choi, DH; Kim, K; Jung, HA; Park, K
    View PubMed
  • HISTOPATHOLOGY 2023 10.1111/his.14894 Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinoma Hong, TH; Hwang, S; Choi, YL; Lee, GEH; Park, S; Ahn, MJ; Lee, Y; Jeon, YJ; Lee, J; Shin, S; Park, SY; Cho, JH; Choi, YS; Kim, J; Shim, YM; Cho, JH; Kim, HK
    View PubMed
  • CLIN CANCER RES 2023 10.1158/1078-0432.CCR-22-3549 Clinicopathologic and Molecular Subtyping of EGFR Mutation-Response Jung, HA; Lim, J; Choi, YL; Kim, J; Park, K
    View PubMed
  • PATHOLOGY 2023 10.1016/j.pathol.2022.07.016 The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer Yu, SL; Hsiao, YJ; Cooper, WA; Choi, YL; Aviles-Salas, A; Chou, TY; Coudry, R; Raskin, GA; Fox, SB; Huang, CC; Jeon, YK; Ko, YH; Ku, WH; Kwon, GY; Leslie, CONNULL; Lin, MC; Lou, PJ; Scapulatempo-Neto, C; Ramirez, SM; Savelov, N; Shim, HS; Torres, COL; Cunha, IW; Zavalishina, L; Chen, YM
    View PubMed
  • NANO LETT 2023 10.1021/acs.nanolett.2c04761 Plasmonic-Magnetic Active Nanorheology for Intracellular Viscosity Lee, S; Jung, IS; Lee, S; Cho, E; Jung, S; Ih, S; Kim, YG; Hong, S; Choi, YL; Shin, J; Park, S
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.001 Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer Park, J; Cho, SY; Chang, ES; Sung, M; Song, JY; Jung, K; Kim, SS; Shin, YK; Choi, YL
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2021.1572 Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing-Based NTRKFusion Detection in South Korea Lee, SE; Lee, MS; Jeon, YK; Shim, HS; Kang, J; Kim, J; Choi, YL
    View PubMed
  • LUNG CANCER 2023 10.1016/j.lungcan.2022.11.009 Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study Subramanian, J; Leighl, NB; Choi, YL; Chou, TY; Gregg, J; Hui, R; Marchetti, A; Silvey, M; Makin, R; Gillespie-Akar, L; Taylor, A; Kahangire, DA; Bailey, T; Chau, M; Navani, N
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12112618 Solitary Pulmonary Capillary Hemangioma: CT and PET-CT Features with Clinicopathologic Correlation Kim, MJ; Hong, W; Kim, TJ; Han, J; Choi, YL; Choi, JY; Lee, SM; Hwang, SH
    View PubMed
  • CLIN CANCER RES 2022 10.1158/1078-0432.CCR-22-0879 Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC br Jung, HA; Lim, J; Choi, YL; Lee, SH; Joung, JG; Jeon, YJ; Choi, JW; Shin, S; Cho, JH; Kim, HK; Choi, YS; Zo, JI; Shim, YM; Park, S; Sun, JM; Ahn, JS; Ahn, MJ; Han, JH; Park, WY; Kim, J; Park, K
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.892918 Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing An, S; Koh, HH; Chang, ES; Choi, J; Song, JY; Lee, MS; Choi, YL
    View PubMed
  • JAMA ONCOL 2022 10.1001/jamaoncol.2022.2310 Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer The Neo-PATH Phase 2 Nonrandomized Clinical Trial Ahn, HK; Sim, SH; Suh, KJ; Kim, MH; Jeong, JH; Kim, JY; Lee, DW; Ahn, JH; Chae, H; Lee, KH; Kim, JH; Lee, KS; Sohn, JH; Choi, YL; Im, SA; Jung, KH; Park, YH
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.843 Selection Strategies and Practical Application of BRAF V600E-Mutated Non-Small Cell Lung Carcinoma Hwang, I; Choi, YL; Lee, H; Hwang, S; Lee, B; Yang, H; Chelakkot, C; Han, J
    View PubMed
  • INSIGHTS IMAGING 2022 10.1186/s13244-022-01235-2 Reappraising the clinical usability of consolidation-to-tumor ratio on CT in clinical stage IA lung cancer Yoon, DW; Kim, CH; Hwang, S; Choi, YL; Cho, JH; Kim, HK; Choi, YS; Kim, J; Shim, YM; Shin, S; Lee, HY
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12061450 NTRK Fusions in 1113 Solid Tumors in a Single Institution Bang, H; Lee, MS; Sung, M; Choi, J; An, S; Kim, SH; Lee, SE; Choi, YL
    View PubMed
  • CLIN CANCER RES 2022 10.1158/1078-0432.CCR-21-3646 Continuation of Pembrolizumab with Additional Chemotherapy after Progression with PD-1/PD-L1 Inhibitor Monotherapy in Patients with Advanced NSCLC: A Randomized, Placebo-Controlled Phase II Study Jung, HA; Park, S; Choi, YL; Lee, SH; Ahn, JS; Ahn, MJ; Sun, JM
    View PubMed
  • CANCERS 2022 10.3390/cancers14123011 The High Proportion of Discordant EGFR Mutations among Multiple Lung Tumors Lee, H; Park, JH; Han, J; Shim, YM; Kim, J; Choi, YS; Kim, HK; Cho, JH; Choi, YL; Kim, WS
    View PubMed
  • J CLIN ONCOL 2022 10.1200/JCO.21.02010 Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer Park, S; Ock, CY; Kim, H; Pereira, S; Park, S; Ma, M; Choi, S; Kim, S; Shin, S; Aum, BJ; Paeng, K; Yoo, D; Cha, H; Park, S; Suh, KJ; Jung, HA; Kim, SH; Kim, YJ; Sun, JM; Chung, JH; Ahn, JS; Ahn, MJ; Lee, JS; Park, K; Song, SY; Bang, YJ; Choi, YL; Mok, TS; Lee, SH
    View PubMed
  • EUR J CANCER 2022 10.1016/j.ejca.2022.04.011 Artificial intelligence-powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response Choi, S; Cho, SI; Ma, M; Park, S; Pereira, S; Aum, BJ; Shin, S; Paeng, K; Yoo, D; Jung, W; Ock, CY; Lee, SH; Choi, YL; Chung, JH; Mok, TS; Kim, H; Kim, S
    View PubMed
  • EUR J CANCER 2022 10.1016/j.ejca.2022.03.034 Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer Park, S; Noh, JM; Choi, YL; Chi, SA; Kim, K; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Sun, JM
    View PubMed
  • LUNG CANCER 2022 10.1016/j.lungcan.2022.04.005 Prognostic impact of micropapillary and solid histological subtype on patients undergoing curative resection for stage I lung adenocarcinoma according to the extent of pulmonary resection and lymph node assessment Jeon, YJ; Lee, J; Shin, S; Cho, JH; Choi, YS; Kim, J; Zo, JI; Shim, YM; Choi, YL; Kim, HK
    View PubMed
  • AM J CANCER RES 2022 Expression of SLC22A18 regulates oxaliplatin resistance by the ERK in colorectal cancer Kim, TW; Pyo, DH; Ko, E; Yun, NH; Song, SJ; Choi, SM; Hong, HK; Kim, SH; Choi, YL; Lee, J; Lee, WY; Cho, YB
    View PubMed
  • CANCER-AM CANCER SOC 2022 10.1002/cncr.34176 Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma Park, S; Oh, D; Choi, YL; Chi, SA; Kim, K; Ahn, MJ; Sun, JM
    View PubMed
  • ESMO OPEN 2022 10.1016/j.esmoop.2022.100385 Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study Park, S; Sun, JM; Choi, YL; Oh, D; Kim, HK; Lee, T; Chi, SA; Lee, SH; Choi, YS; Jung, SH; Ahn, MJ; Ahn, YC; Park, K; Shim, YM
    View PubMed
  • LAB INVEST 2021 10.1038/s41374-021-00699-y Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling Kang, SU; Cho, SY; Jeong, H; Han, JN; Chae, H; Yang, HB; Sung, CO; Choi, YL; Shin, YK; Kwon, MJ
    View PubMed
  • J THORAC ONCOL 2021 10.1016/j.jtho.2021.09.007 Lung Cancer in Korea Park, S; Choi, CM; Hwang, SS; Choi, YL; Kim, HY; Kim, YC; Kim, YT; Lee, HY; Song, SY; Ahn, MJ
    View PubMed
  • TRANSL LUNG CANCER R 2021 10.21037/tlcr-21-691 Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment Hwang, S; Hong, TH; Park, S; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Choi, YL; Lee, SH
    View PubMed
  • ONCOTARGETS THER 2021 10.2147/OTT.S313669 Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets Dalurzo, ML; Aviles-Salas, A; Soares, FA; Hou, YY; Li, Y; Stroganova, A; Oz, B; Abdillah, A; Wan, H; Choi, YL
    View PubMed
  • J PATHOL 2021 10.1002/path.5779 NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions Kim, JH; Hong, JH; Choi, YL; Lee, JA; Seo, MK; Lee, MS; An, SB; Sung, MJ; Cho, NY; Kim, SS; Shin, YK; Kim, S; Kang, GH
    View PubMed
  • DIAGNOSTICS 2021 10.3390/diagnostics11091695 Real-World Analysis of the EGFR Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer Lee, H; Han, J; Choi, YL
    View PubMed
  • CANCERS 2021 10.3390/cancers13184659 PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score Cho, YA; Lee, H; Kim, DG; Kim, H; Ha, SY; Yoon-La Choi; Jang, KT; Kim, KM
    View PubMed
  • EUR J NUCL MED MOL I 2021 10.1007/s00259-021-05487-w Trimodality therapy for locally advanced esophageal squamous cell carcinoma: the role of volume-based PET/CT in patient management and prognostication Choi, Y; Choi, JY; Hong, TH; Choi, YL; Oh, D; Woo, SY; Shim, YM; Zo, JI; Kim, HK; Lee, KS
    View PubMed
  • CANCERS 2021 10.3390/cancers13133122 Overexpression of Replication-Dependent Histone Signifies a Subset of Dedifferentiated Liposarcoma with Increased Aggressiveness Yoo, Y; Park, SY; Jo, EB; Choi, M; Lee, KW; Hong, D; Lee, S; Lee, CR; Lee, Y; Um, JY; Park, JB; Seo, SW; Yoon-La Choi; Kim, S; Lee, SG; Choi, M
    View PubMed
  • CANCER 2021 10.1002/cncr.33571 High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean lung liquid versus invasive biopsy program Park1, S; Olsen, S; Ku, BM; Lee, MS; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Choi, YL; Ahn, MJ
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2020.434 TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis Jung1, K; Choi, JS; Koo, BM; Kim, YJ; Song, JY; Sung, M; Chang, ES; Noh, KW; An, S; Lee, MS; Song, K; Lee, H; Kim, RN; Shin, YK; Oh, DY; Choi, YL
    View PubMed
  • NAT COMMUN 2020 10.1038/s41467-020-19933-0 Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome Park1, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z
    View PubMed
  • J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018 Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status Lee1, J; Choi, YL; Han, J; Park, S; Jung, HA; Su, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • THORAC CANCER 2020 10.1111/1759-7714.13648 Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma A single-institute experience of 10 cases Cho1, YA; Choi, YL; Hwang, I; Lee, K; Cho, JH; Han, J
    View PubMed
  • CANCER IMMUNOL IMMUN 2020 10.1007/s00262-020-02766-7 Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect Lee1, J; Kim, B; Jung, HA; Choi, YL; Sun, JM
    View PubMed
  • J THORAC DIS 2020 10.21037/jtd-20-1716 Clinicoradiopathological features and prognosis according to genomic alterations in patients with resected lung adenocarcinoma Choi1, Y; Kim, KH; Jeong, BH; Lee, KJ; Kim, H; Kwon, OJ; Kim, J; Choi, YL; Lee, HY; Um, SW
    View PubMed
  • J IMMUNOTHER CANCER 2020 10.1136/jitc-2020-001199 Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity Hong1, TH; Cha, H; Shim, JH; Lee, B; Chung, J; Lee, C; Kim, NKD; Choi, YL; Hwang, S; Lee, Y; Park, S; Jung, HA; Kim, JY; Park, YH; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH; Park, WY
    View PubMed
  • ISCIENCE 2020 10.1016/j.isci.2020.101386 Earlier-Phased Cancer Immunity Cycle Strongly Influences Cancer Immunity in Operable Never-Smoker Lung Adenocarcinoma Kim1, HK; Joung, JG; Choi, YL; Lee, SH; Park, BJ; Choi, YS; Ryu, D; Nam, JY; Lee, MS; Park, WY; Hwang, S; Cha, H; Kim, HS; Lee, S; Jung, Y; Lee, JE; Doh, J; Paik, S; Kang, JH; Lee, J; Kim, J
    View PubMed
  • J TRANSL MED 2020 10.1186/s12967-020-02473-y PDX models of human lung squamous cell carcinoma consideration of factors in preclinical and co-clinical applications Jung1, HY; Kim, TH; Lee, JE; Kim, HK; Cho, JH; Choi, YS; Shin, S; Lee, SH; Rhee, H; Lee, HK; Choi, HJ; Jang, HY; Lee, S; Kang, JH; Choi, YA; Lee, S; Lee, J; Choi, YL; Kim, J
    View PubMed
  • ANN ONCOL 2020 10.1016/j.annonc.2020.04.004 HLA-corrected tumor mutation burden and homologous recombination de fi ciency for the prediction of response to PD -(L)1 blockade in advanced non -small -cell lung cancer patients Shim1, JH; Kim, HS; Cha, H; Kim, S; Kim, TM; Anagnostou, V; Choi, YL; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Park, WY; Lee, SH
    View PubMed
  • GENOME BIOL 2020 10.1186/s13059-020-02076-2 Dysregulation of cancer genes by recurrent intergenic fusions Yun1, JW; Yang, LX; Park, HY; Lee, CW; Cha, HG; Shin, HT; Noh, KW; Choi, YL; Park, WY; Park, PJ
    View PubMed
  • EUR J CANCER 2020 10.1016/j.ejca.2020.03.029 Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma Lee1, J; La Choi, Y; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Sun, JM
    View PubMed
  • CLIN LUNG CANCER 2020 10.1016/j.cllc.2019.11.006 Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests Byeon1, S; Lee, B; Park, WY; Choi, YL; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH
    View PubMed
  • NAT COMMUN 2020 10.1038/s41467-020-16164-1 Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma Kim1, N; Kim, HK; Lee, K; Hong, Y; Cho, JH; Choi, JW; Lee, J; Suh, YL; Ku, BM; Eum, HH; Choi, S; Choi, YL; Joung, JG; Park, WY; Jung, HA; Sun, JM; Lee, SN; Ahn, JS; Park, K; Ahn, MJ; Lee, HO
    View PubMed
  • J MOL DIAGN 2020 10.1016/j.jmoldx.2019.10.015 Junction Location Identifier (JuLI) Accurate Detection of DNA Fusions in Clinical Sequencing for Precision Oncology Shin1, HT; Kim, NKD; Yun, JW; Lee, B; Kyung, S; Lee, KW; Ryu, D; Kim, J; Bae, JS; Park, D; Choi, YL; Lee, SH; Ahn, MJ; Park, K; Park, WY
    View PubMed
  • MOL THER-ONCOLYTICS 2020 10.1016/j.omto.2019.12.009 IRS2 Amplification as a Predictive Biomarker in Response to Ceritinib in Small Cell Lung Cancer Lee1, MS; Jung, K; Song, JY; Sung, MJ; Ahn, SB; Lee, B; Oh, DY; Choi, YL
    View PubMed
  • Front Oncol 2020 10.3389/fonc.2019.01574 UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer Kim1, YJ; Lee, GH; Han, JN; Song, K; Choi, JS; Choi, YL; Shin, YK
    View PubMed
  • BIOMOLECULES 2020 10.3390/biom10010051 Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting Yang1, H; Park, H; Lee, YJ; Choi, JY; Kim, T; Rajasekaran, N; Lee, S; Song, K; Hong, S; Choi, JS; Shim, H; Kim, YD; Hwang, S; Choi, YL; Shin, YK
    View PubMed
  • BREAST CANCER RES 2019 10.1186/s13058-019-1197-x High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy Na1, H; Han, J; Ka, NL; Lee, MH; Choi, YL; Shin, YK; Lee, MO
    View PubMed
  • J CLIN MED 2019 10.3390/ijms20194794 Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation Lee1, SE; Kim, YJ; Sung, M; Lee, MS; Han, J; Kim, HK; Choi, YL
    View PubMed
  • J MOL MED-JMM 2019 10.1007/s00109-019-01815-8 Molecular changes in solitary fibrous tumor progression Park1, HK; Yu, DB; Sung, MJ; Oh, E; Kim, M; Song, JY; Lee, MS; Jung, K; Noh, KW; An, S; Song, K; Nam, DH; Kim, YJ; Choi, YL
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14915 Nomogram for prediction of lymph node metastasis in patients with superficial esophageal squamous cell carcinoma Min1, BH; Yang, JW; Min, YW; Baek, SY; Kim, S; Kim, HK; Choi, YS; Shim, YM; Choi, YL; Zo, JI
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-019-06445-9 Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index Lee1, JH; Yoon, YC; Seo, SW; Choi, YL; Kim, HS
    View PubMed
  • EUR J CANCER 2019 10.1016/j.ejca.2019.08.001 Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing Kim1, HS; Cha, H; Kim, JH; Park, WY; Choi, YL; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, SH
    View PubMed
  • J PLAST RECONSTR AES 2019 10.1016/j.bjps.2019.05.021 Capsule biopsy of acellular dermal matrix (ADM) to predict future capsular contracture in two-stage prosthetic breast reconstruction Kim1, A; Jung, JH; Choi, YL; Pyon, JK
    View PubMed
  • LAB INVEST 2019 10.1038/s41374-019-0263-4 Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology Kim1, YJ; Kim, M; Park, HK; Yu, DB; Jung, K; Song, K; Choi, YL
    View PubMed
  • J CLIN ONCOL 2019 10.1200/JCO.2017.77.3184 Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial Cho1, J; Kim, HS; Ku, BM; Choi, YL; Cristescu, R; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • CANCER SCI 2019 10.1111/cas.14036 Adipogenesis induces growth inhibition of dedifferentiated liposarcoma Kim1, YJ; Yu, DB; Kim, M; Choi, YL
    View PubMed
  • LUNG CANCER 2019 10.1016/j.lungcan.2019.05.024 Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma Park1, S; Shim, JH; Lee, B; Cho, I; Park, WY; Kim, Y; Lee, SH; Choi, YL; Han, J; Ahn, JS; Ahn, MJ; Park, K; Sun, JM
    View PubMed
  • Front Oncol 2019 10.3389/fonc.2019.00667 Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer Kwon1, MJ; Lee, JE; Jeong, J; Woo, SU; Han, J; Kang, BI; Kim, JE; Moon, Y; Lee, SB; Lee, S; Choi, YL; Kwon, Y; Song, K; Gong, G; Shin, YK
    View PubMed
  • PATHOL RES PRACT 2019 10.1016/j.prp.2019.152441 Histopathologic characteristics of advanced-stage ROS1-rearranged non-small-cell lung cancers Park1, E; Choi, YL; Ahn, MJ; Han, J
    View PubMed
  • MOL ONCOL 2019 10.1002/1878-0261.12478 Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma Yu1, N; Yong, S; Kim, HK; Choi, YL; Jung, Y; Kim, D; Seo, J; Lee, YE; Baek, D; Lee, J; Lee, S; Lee, JE; Kim, J; Kim, J; Lee, S
    View PubMed
  • J IMMUNOTHER CANCER 2019 10.1186/s40425-019-0609-x Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma Park1, S; Joung, JG; Min, YW; Nam, JY; Ryu, D; Oh, D; Park, WY; Lee, SH; Choi, YL; Ahn, JS; Ahn, MJ; Park, K; Sun, JM
    View PubMed
  • CLIN LUNG CANCER 2019 10.1016/j.cllc.2018.12.021 Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients Da Nam1, B; Kim, TJ; Park, K; Ahn, MJ; Choi, YL; Chung, MJ; Kim, TS; Lee, KS
    View PubMed
  • CLIN LUNG CANCER 2019 10.1016/j.cllc.2018.12.020 Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor Lee1, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Choi, YL; Ahn, MJ
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-5713-2 Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells Jo1, EB; Lee, YS; Lee, H; Park, JB; Park, H; Choi, YL; Hong, D; Kim, SJ
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.151 Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea Byeon1, S; Kim, Y; Lim, SW; Cho, JH; Park, S; Lee, J; Sun, JM; Choi, YL; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.125 EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy Park1, SE; Noh, JM; Kim, YJ; Lee, HS; Cho, JH; Lim, SW; Ahn, YC; Pyo, H; Choi, YL; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • LUNG CANCER 2019 10.1016/j.lungcan.2019.01.012 Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer Lee1, K; Kim, Y; Jung, HA; Lee, SH; Ahn, JS; Ahn, MJ; Park, K; Choi, YL; Sun, JM
    View PubMed
  • J THORAC ONCOL 2019 10.1016/j.jtho.2018.10.150 Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC Kim1, Y; Lee, B; Shim, JH; Lee, SH; Park, WY; Choi, YL; Sun, JM; Ahn, JS; Ahn, MJ; Park, K
    View PubMed
  • J TRANSL MED 2018 10.1186/s12967-018-1658-5 Status of programmed death-ligand 1 expression in sarcomas Park1, HK; Kim, M; Sung, M; Lee, SE; Kim, YJ; Choi, YL
    View PubMed
  • ASIA-PAC J CLIN ONCO 2018 10.1111/ajco.12769 Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma Cho1, CW; Lee, KW; Park, H; Kim, HJ; Park, JB; Choi, YL; Yu, JI; Lee, SJ; Choi, DI; Kim, SJ
    View PubMed
  • CLIN CANCER RES 2018 10.1158/1078-0432.CCR-17-3492 Integrin beta 3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC Noh1, KW; Sohn, I; Song, JY; Shin, HT; Kim, YJ; Jung, K; Sung, M; Kim, M; An, S; Han, J; Lee, SH; Lee, MS; Choi, YL
    View PubMed
  • J THORAC ONCOL 2018 10.1016/j.jtho.2018.05.026 Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice Park1, S; Ahn, BC; Lim, SW; Sun, JM; Kim, HR; Hong, MH; Lee, SH; Ahn, JS; Park, K; La Choi, Y; Cho, BC; Ahn, MJ
    View PubMed
  • LUNG CANCER 2018 10.1016/j.lungcan.2018.06.009 Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma Lee1, J; Jung, HA; Kim, Y; Choi, S; Han, J; Choi, YL; Lee, SH; Ahn, JS; Park, K; Sun, JM
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-25800-2 Genomic alterations of ground-glass nodular lung adenocarcinoma Lee1, H; Joung, JG; Shin, HT; Kim, DH; Kim, Y; Kim, H; Kwon, OJ; Shim, YM; Lee, HY; Lee, KS; Choi, YL; Park, WY; Hayes, DN; Um, SW
    View PubMed
  • NAT COMMUN 2018 10.1038/s41467-018-04129-4 Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures Kan1, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH
    View PubMed
  • CANCER BIOL THER 2018 10.1080/15384047.2018.1423913 Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer Kim1, YJ; Sung, M; Oh, E; Vrancken, MV; Song, JY; Jung, K; Choi, YL
    View PubMed
  • J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e123 Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors Sim1, J; Kim, H; Hyeon, J; Choi, YL; Han, J
    View PubMed
  • WORLD J SURG 2018 10.1007/s00268-017-4157-6 Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival Rhu1, J; Cho, CW; Lee, KW; Park, H; Park, JB; Choi, YL; Kim, SJ
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2016.591 Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer Cho1, JH; Zhou, W; Choi, YL; Sun, JM; Choi, H; Kim, TE; Dolled-Filhart, M; Emancipator, K; Rutkowski, MA; Kim, J
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-017-18642-x Droplet digital PCR-based &ITEGFR &ITmutation detection with an internal quality control index to determine the quality of DNA Kim1, SS; Choi, HJ; Kim, JJ; Kim, MS; Lee, IS; Byun, B; Jia, LN; Oh, MR; Moon, Y; Parka, S; Choi, JS; Chae, SW; Nam, BH; Kim, JS; Kim, J; Min, BS; Lee, JS; Won, JK; Cho, S; Choi, YL; Shin, YK
    View PubMed
  • CAN J SURG 2017 10.1503/cjs.005917 Comparison of retroperitoneal liposarcoma extending into the inguinal canal and inguinoscrotal liposarcoma Rhu1, J; Cho, CW; Lee, KW; Park, H; Park, JB; Choi, Y; Kim, SJ
    View PubMed
  • NAT COMMUN 2017 10.1038/s41467-017-01470-y Prevalence and detection of low-allele-fraction variants in clinical cancer samples Shin1, HT; Choi, YL; Yun, JW; Kim, NKD; Kim, SY; Jeon, HJ; Nam, JY; Lee, C; Ryu, D; Kim, SC; Park, K; Lee, E; Bae, JS; Son, DS; Joung, JG; Lee, J; Kim, ST; Ahn, MJ; Lee, SH; Ahn, JS; Lee, WY; Oh, BY; Park, YH; Lee, JE; Lee, KH; Kim, HC; Kim, KM; Im, YH; Park, K; Park, PJ; Park, WY
    View PubMed
  • CLIN LUNG CANCER 2017 10.1016/j.cllc.2017.04.008 Programmed Death Ligand 1 Expression in Paired Non-Small-Cell Lung Cancer Tumor Samples Cho1, JH; Sorensen, SF; Choi, YL; Feng, Y; Kim, TE; Choi, H; Georgsen, JB; Dolled-Filhart, M; Emancipator, K; Meldgaard, P; Sun, JM; Kim, HK; Choi, YS; Shim, YM; Zhou, W; Hager, H; Kim, J
    View PubMed
  • J PATHOL 2017 10.1002/path.4950 Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer Noh1, KW; Lee, MS; Lee, SE; Song, JY; Shin, HT; Kim, YJ; Oh, DY; Jung, K; Sung, M; Kim, M; An, S; Han, J; Shim, YM; Zo, JI; Kim, J; Park, WY; Lee, SH; Choi, YL
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.21150 Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer Kwon1, MJ; Kim, RN; Song, K; Jeon, S; Jeong, HM; Kim, JS; Han, J; Hong, S; Oh, E; Choi, JS; An, J; Pollack, JR; Choi, YL; Park, CK; Shin, YK
    View PubMed
  • PATHOLOGY 2017 10.1016/j.pathol.2017.05.010 Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer Choi1, JS; Kim, KH; Oh, E; Shin, YK; Seo, J; Kim, SH; Park, S; Choi, YL
    View PubMed
  • Neoplasia 2017 10.1016/j.neo.2017.07.005 Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions Rajasekaran1, N; Jung, HS; Bae, SH; Chelakkot, C; Hong, S; Choi, JS; Yim, DS; Oh, YK; Choi, YL; Shin, YK
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.347 Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients Lee1, MS; Jung, EA; An, SB; Kim, YJ; Oh, DY; Song, JY; Um, SW; Han, J; Choi, YL
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.322 Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies Heo1, EJ; Cho, YJ; Cho, WC; Hong, JE; Jeon, HK; Oh, DY; Choi, YL; Song, SY; Choi, JJ; Bae, DS; Lee, YY; Choi, CH; Kim, TJ; Park, WY; Kim, BG; Lee, JW
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0185826 Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans Oh1, E; Jeong, HM; Kwon, MJ; Ha, SY; Park, HK; Song, JY; Kim, YJ; Choi, JS; Lee, EH; Lee, J; Choi, YL; Shin, YK
    View PubMed
  • Oncogenesis 2017 10.1038/oncsis.2017.87 ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells Jeong1, HM; Han, J; Lee, SH; Park, HJ; Lee, HJ; Choi, S; Lee, YM; Choi, YL; Shin, YK; Kwon, MJ
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.18618 Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients Jeong1, HM; Kim, RN; Kwon, MJ; Oh, E; Han, J; Lee, SK; Choi, JS; Park, S; Nam, SJ; Gong, GY; Nam, JW; Choi, DH; Lee, H; Nam, BH; Choi, YL; Shin, YK
    View PubMed
  • CYTOTHERAPY 2017 10.1016/j.jcyt.2017.05.008 Therapeutic strategies for locally recurrent and metastatic de-differentiated liposarcoma with herpes simplex virus-thymidine kinase-expressing mesenchymal stromal cells Lee1, H; Jo, EB; Kim, SJ; Yang, HM; Kim, YM; Sung, YC; Park, JB; Hong, D; Park, H; Choi, YL; Kim, SJ
    View PubMed
  • J CLIN ONCOL 2017 10.1200/JCO.2016.71.3701 Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement Lim1, SM; Kim, HR; Lee, JS; Lee, KH; Lee, YG; JooMin, Y; Cho, EK; Lee, SS; Kim, BS; Choi, MY; Shim, HS; Chung, JH; La Choi, Y; Lee, MJ; Kim, M; Kim, JH; Ali, SM; Ahn, MJ; Cho, BC
    View PubMed
  • J THORAC ONCOL 2017 10.1016/j.jtho.2017.04.031 MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values Lee1, GD; Lee, SE; Oh, DY; Yu, DB; Jeong, HM; Kim, J; Hong, S; Jung, HS; Oh, E; Song, JY; Lee, MS; Kim, M; Jung, K; Kim, J; Shin, YK; Choi, YL; Kim, HR
    View PubMed
  • MEDICINE 2017 10.1097/MD.0000000000007537 Single-center experience with intra-abdominal liposarcoma Optimal minimum duration for postoperative remnant tumor screening Rhu1, J; Cho, CW; Lee, KW; Park, H; Park, JB; Choi, YL; Kim, SJ
    View PubMed
  • BMC CANCER 2017 10.1186/s12885-017-3525-9 Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification Oh1, DY; Jung, K; Song, JY; Kim, S; Shin, S; Kwon, YJ; Oh, E; Park, WY; Song, SY; Choi, YL
    View PubMed
  • CLIN RADIOL 2017 10.1016/j.crad.2017.02.003 Diagnostic performance of conventional MRI parameters and apparent diffusion coefficient values in differentiating between benign and malignant soft-tissue tumours Song1, Y; Yoon, YC; Chong, Y; Seo, SW; Choi, YL; Sohn, I; Kim, MJ
    View PubMed
  • PATHOL RES PRACT 2017 10.1016/j.prp.2017.02.021 Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine Yang1, JW; Choi, YL
    View PubMed
  • LUNG CANCER 2017 10.1016/j.lungcan.2017.04.009 Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq Zhang1, L; Li, SY; Choi, YL; Lee, J; Gong, ZL; Liu, XQ; Pei, YF; Jiang, AW; Ye, MZ; Mao, M; Zhang, XG; Kim, J; Chen, RH
    View PubMed
  • BREAST CANCER RES TR 2017 10.1007/s10549-017-4234-4 MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer Han1, J; Choi, YL; Kim, H; Choi, JY; Lee, SK; Lee, JE; Choi, JS; Park, S; Choi, JS; Kim, YD; Nam, SJ; Nam, BH; Kwon, MJ; Shin, YK
    View PubMed
  • WORLD J SURG 2017 10.1007/s00268-017-3908-8 Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma Kim1, KW; Kim, HK; Kim, J; Shim, YM; Ahn, MJ; Choi, YL
    View PubMed
  • Gut. 2017 Feb;66(2):215-225. doi: 10.1136/gutjnl-2015-311238. Epub 2016 Aug 9. Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer Jang HJ11,2,3, Lee HS1,2,4,5, Burt BM4, Lee GK5, Yoon KA5,6, Park YY2, Sohn BH2, Kim SB2, Kim MS1, Lee JM1, Joo J7, Kim SC8, Yun JS9, Na KJ9, Choi YL10, Park JL11, Kim SY11, Lee YS12, Han L13,14, Liang H13, Mak D15, Burks JK15, Zo JI16, Sugarbaker DJ4, Shim YM16, Lee JS2.
    View PubMed
  • Ann Oncol. 2017 Feb 1;28(2):292-297. doi: 10.1093/annonc/mdw559. Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial Lee SH11, Lee JK2, Ahn MJ1, Kim DW2, Sun JM1, Keam B2, Kim TM2, Heo DS2, Ahn JS1, Choi YL3, Min HS4, Jeon YK4, Park K1.
    View PubMed
  • Oncotarget. 2017 Jan 10;8(2):3519-3527. doi: 10.18632/oncotarget.13864. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma Park JK11, Lee YJ1, Lee JK1, Lee KT1, Choi YL2, Lee KH1,3.
    View PubMed
  • Oncotarget. 2016 Dec 13;7(50):82876-82888. doi: 10.18632/oncotarget.12657. LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients Kim YJ11, Hong S2, Sung M1, Park MJ2, Jung K1,3, Noh KW1,3, Oh DY1,3, Lee MS1,3, Oh E1,3, Shin YK2,4, Choi YL1,3,5.
    View PubMed
  • J Thorac Oncol. 2016 Dec;11(12):2129-2140. doi: 10.1016/j.jtho.2016.08.142. Epub 2016 Sep 9. Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma Li S11, Choi YL2, Gong Z1, Liu X1, Lira M3, Kan Z3, Oh E2, Wang J4, Ting JC4, Ye X4, Reinhart C4, Liu X5, Pei Y5, Zhou W5, Chen R5, Fu S6, Jin G6, Jiang A1, Fernandez J3, Hardwick J3, Kang MW7, I H8, Zheng H1, Kim J2, Mao M9.
    View PubMed
  • Intern Med. 2016;55(21):3105-3111. Epub 2016 Nov 1. Triple Gene Analysis Using Samples Obtained by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Lee K11, Um SW, Jeong BH, Yang JW, Choi YL, Han J, Kim H, Kwon OJ.
    View PubMed
  • J Thorac Dis. 2016 Nov;8(11):3175-3186. doi: 10.21037/jtd.2016.11.25. The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations Cha YK11, Lee HY2, Ahn MJ3, Park K3, Ahn JS3, Sun JM3, Choi YL4, Lee KS2.
    View PubMed
  • Oncotarget. 2016 Oct 11;7(41):67302-67313. doi: 10.18632/oncotarget.11693. Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma Choi ER11, Lee HY1, Jeong JY2, Choi YL3, Kim J4, Bae J1, Lee KS1, Shim YM4.
    View PubMed
  • Cancer. 2016 Oct;122(19):3024-31. doi: 10.1002/cncr.30135. Epub 2016 Jun 17. Efficacy and Safety of Dovitinib in Pretreated Patients With Advanced Squamous Non-Small Cell Lung Cancer With FGFR1 Amplification: A Single-Arm, Phase 2 Study Lim SH11, Sun JM1, Choi YL2, Kim HR3, Ahn S2, Lee JY1, Lee SH1, Ahn JS1, Park K1, Kim JH3, Cho BC4, Ahn MJ5.
    View PubMed
  • Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy Yu JI11, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.
    View PubMed
  • J Appl Clin Med Phys. 2016 Sep;17(5):1-10. doi: 10.1120/jacmp.v17i5.6314. Correlation of quantitative dynamic contrast-enhanced MRI with microvascular density in necrotic, partial necrotic, and viable liver tumors in a rabbit model Moon J11,2, Kim JH1, Choi D1, Yang J3, Lee MW1, Choi YL4, Rhim Md H1.
    View PubMed
  • Medicine (Baltimore). 2016 Aug;95(32):e4435. doi: 10.1097/MD.0000000000004435. Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control Park H11, Lee S, Kim B, Lim do H, Choi YL, Choi GS, Kim JM, Park JB, Kwon CH, Joh JW, Kim SJ.
    View PubMed
  • Epigenomics. 2016 Aug;8(8):1061-77. doi: 10.2217/epi-2016-0038. Epub 2016 Jun 8. Efficiency of methylated DNA immunoprecipitation bisulphite sequencing for whole-genome DNA methylation analysis Jeong HM11, Lee S2, Chae H3, Kim R1,4, Kwon MJ5,6, Oh E7,8, Choi YL7,8,9, Kim S10,11,12, Shin YK1,4,12,13,14.
    View PubMed
  • Thyroid. 2016 Jul;26(7):901-10. doi: 10.1089/thy.2015.0488. Epub 2016 Jun 6. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population Lee SE11, Hwang TS1, Choi YL2, Han HS1, Kim WS1, Jang MH1, Kim SK3, Yang JH4.
    View PubMed
  • J Thorac Oncol. 2016 Jul;11(7):1003-11. doi: 10.1016/j.jtho.2016.04.007. Epub 2016 Apr 18. Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases Sun JM11, Zhou W2, Choi YL1, Choi SJ1, Kim SE1, Wang Z2, Dolled-Filhart M2, Emancipator K2, Wu D2, Weiner R2, Frisman D3, Kim HK1, Choi YS1, Shim YM1, Kim J4.
    View PubMed
  • J Clin Pathol. 2016 Jul;69(7):586-92. doi: 10.1136/jclinpath-2015-203314. Epub 2015 Dec 15. Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion Sung JY11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Kang SY3, Choi YL3, Kwon GY3.
    View PubMed
  • Oncotarget. 2016 Jun 14;7(24):36101-36114. doi: 10.18632/oncotarget.9137. Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma Lee MS11,2, Kim RN3,4, I H5,6, Oh DY1,2, Song JY2, Noh KW1,2, Kim YJ1,2, Yang JW7, Lira ME8, Lee CH9, Lee MK10, Kim YD5, Mao M8,11, Han J12, Kim J13, Choi YL1,2,12.
    View PubMed
  • Am J Hum Genet. 2016 May 5;98(5):843-56. doi: 10.1016/j.ajhg.2016.03.017. Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing Yang L11, Lee MS2, Lu H3, Oh DY2, Kim YJ4, Park D4, Park G5, Ren X6, Bristow CA7, Haseley PS8, Lee S1, Pantazi A9, Kucherlapati R10, Park WY11, Scott KL3, Choi YL12, Park PJ13.
    View PubMed
  • Annu Rev Pathol. 2016 May 23;11:283-312. doi: 10.1146/annurev-pathol-012615-044446. Epub 2016 Feb 22. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies Lee JK11, Choi YL2,3, Kwon M4,5, Park PJ6.
    View PubMed
  • Oncotarget. 2016 May 24;7(21):30691-701. doi: 10.18632/oncotarget.8749. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma Kim HS11, Lee SE2, Bae YS3, Kim DJ4, Lee CG5, Hur J6, Chung H7, Park JC7, Shin SK7, Lee SK7, Lee YC7, Kim HR1, Shim YM8, Jewell SS9, Kim H3, Choi YL10, Cho BC1.
    View PubMed
  • Oncotarget. 2016 Apr 26;7(17):23874-84. doi: 10.18632/oncotarget.8074. Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers Lee B11,2, Lee T1, Lee SH3,2, Choi YL1,2, Han J1.
    View PubMed
  • Lung Cancer. 2016 Apr;94:22-7. doi: 10.1016/j.lungcan.2016.01.011. Epub 2016 Jan 21. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare Zhao W11, Choi YL2, Song JY3, Zhu Y4, Xu Q1, Zhang F1, Jiang L1, Cheng J1, Zheng G5, Mao M6.
    View PubMed
  • Oncotarget. 2016 Apr 26;7(17):24141-53. doi: 10.18632/oncotarget.8234. Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma Lee SE11, Oh E2,3, Lee B4, Kim YJ2, Oh DY2,3, Jung K2,3, Choi JS5, Kim J6, Kim SJ6, Yang JW7, An J8, Oh YL4, Choi YL4,2,3.
    View PubMed
  • Oncotarget. 2016 Mar 22;7(12):13797-809. doi: 10.18632/oncotarget.7318. Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation Kim N11,2, Cho A2, Watanabe H3,4, Choi YL2,5, Aziz M6, Kassner M6, Joung JG7, Park AK1,2, Francis JM8, Bae JS7, Ahn SM5, Kim KM5, Park JO9, Park WY2,7, Ahn MJ9, Park K9, Koo J10, Yin HH6, Cho J1,2,7.
    View PubMed
  • INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9(3):4123-4128 SPOP mutation in prostate cancers in Korean population: variation in its mutation frequency among ethnic groups Yoon N1, Sung JY, Kang SY, Kwon GY, Choi YL
    View PubMed
  • Eur J Cancer. 2016 Jan;52:1-9. doi: 10.1016/j.ejca.2015.09.019. Epub 2015 Nov 26. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer Lim SH11, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.
    View PubMed
  • CANCER RESEARCH AND TREATMENT, JAN 2016, 48(1):398-402, DOI: 10.4143/crt.2014.254 SEC31A-ALKFusion Gene in Lung Adenocarcinoma Kim RN1, Choi YL, Lee MS, Lira ME, Mao M, Mann D, Stahl J, Licon A, Choi SJ, Van Vrancken, M
    View PubMed
  • Ann Surg. 2015 Dec;262(6):965-71. doi: 10.1097/SLA.0000000000001039. New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma Lee GD11, Lee SE, Kim KM, Kim YH, Ahn JH, Jung S, Choi YL, Kim HR, Park SI, Shim YM.
    View PubMed
  • Oncotarget. 2015 Dec 8;6(39):41916-28. doi: 10.18632/oncotarget.6019. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma Kwon OS11, Oh E2, Park JR1, Lee JS1, Bae GY1, Koo JH3, Kim H4, Choi YL5, Choi YS6, Kim J6, Cha HJ1.
    View PubMed
  • PLoS One. 2015 Dec 7;10(12):e0144162. doi: 10.1371/journal.pone.0144162. eCollection 2015. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples Oh E11,2,3, Choi YL1,2,4,5, Kwon MJ6,7, Kim RN3, Kim YJ1,2, Song JY1,2, Jung KS1,5, Shin YK3.
    View PubMed
  • Oncotarget. 2015 Nov 3;6(34):36219-30. doi: 10.18632/oncotarget.5283. HER2 as a novel therapeutic target for cervical cancer Oh DY11,2,3, Kim S1, Choi YL1,2,3, Cho YJ4, Oh E2,3, Choi JJ4, Jung K3, Song JY2, Ahn SE2, Kim BG4, Bae DS4, Park WY3,5, Lee JW2,3,4, Song S1,2.
    View PubMed
  • Oncotarget. 2015 Oct 13;6(31):32027-38. doi: 10.18632/oncotarget.5184. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer Park YH11,2, Shin HT3, Jung HH2, Choi YL3, Ahn T3, Park K3, Lee A4, Do IG5, Kim JY1,2, Ahn JS1, Park WY3, Im YH1,2.
    View PubMed
  • Medicine (Baltimore). 2015 Oct;94(41):e1753. doi: 10.1097/MD.0000000000001753. Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach Yoon HJ11, Sohn I, Cho JH, Lee HY, Kim JH, Choi YL, Kim H, Lee G, Lee KS, Kim J.
    View PubMed
  • PLoS One. 2015 Oct 7;10(10):e0139112. doi: 10.1371/journal.pone.0139112. eCollection 2015. CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer Kwon MJ11, Han J2, Seo JH3, Song K4, Jeong HM3, Choi JS5, Kim YJ6, Lee SH7, Choi YL8, Shin YK9.
    View PubMed
  • J Clin Neurosci. 2015 Sep;22(9):1425-9. doi: 10.1016/j.jocn.2015.02.036. Epub 2015 Jun 29. Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide Kong DS11, Kim HR2, Choi YR3, Seol HJ1, Lee JI1, Nam DH4.
    View PubMed
  • Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9722-7. doi: 10.1073/pnas.1423827112. Epub 2015 Jul 7. Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia Cha JY11, Wee J2, Jung J3, Jang Y3, Lee B2, Hong GS2, Chang BC4, Choi YL5, Shin YK6, Min HY6, Lee HY6, Na TY6, Lee MO6, Oh U7.
    View PubMed
  • J Clin Oncol. 2015 Aug 20;33(24):2660-6. doi: 10.1200/JCO.2014.60.0130. Epub 2015 Jul 6. Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04 Ahn JS11, Ahn YC1, Kim JH1, Lee CG1, Cho EK1, Lee KC1, Chen M1, Kim DW1, Kim HK1, Min YJ1, Kang JH1, Choi JH1, Kim SW1, Zhu G1, Wu YL1, Kim SR1, Lee KH1, Song HS1, Choi YL1, Sun JM1, Jung SH1, Ahn MJ1, Park K2.
    View PubMed
  • Diagn Cytopathol. 2015 Jul;43(7):539-44. doi: 10.1002/dc.23242. Epub 2014 Nov 26. Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations Song DH11, Lee B1, Shin Y1, Choi IH1, Ha SY1, Lee JJ1, Hong ME1, Choi YL1, Han J1, Um SW2.
    View PubMed
  • Int J Mol Sci. 2015 May 29;16(6):12243-60. doi: 10.3390/ijms160612243. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo Jung HS11,2, Rajasekaran N3, Song SY4, Kim YD5, Hong S6, Choi HJ7, Kim YS8, Choi JS9, Choi YL10, Shin YK11,12,13.
    View PubMed
  • Int J Rheum Dis. 2015 Jun;18(5):514-23. doi: 10.1111/1756-185X.12501. Epub 2014 Dec 20. A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model Lee J11, Hong EC2, Jeong H1, Hwang JW1, Kim H1, Bae EK2, Ahn JK3, Choi YL4, Han J4, Cha HS1, Koh EM1.
    View PubMed
  • Cancer Chemother Pharmacol. 2015 Jun;75(6):1229-36. doi: 10.1007/s00280-015-2740-9. Epub 2015 Apr 23. A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test Choi MK11, Hong JY, Chang WJ, Kim MJ, Kim SM, Jung HA, Do IG, Choi YL, Sun JM, Ahn JS, Park K, Ahn MJ.
    View PubMed
  • Clin Lung Cancer. 2015 May;16(3):228-36. doi: 10.1016/j.cllc.2014.11.002. Epub 2014 Nov 18. Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy Cha YK11, Lee HY2, Ahn MJ3, Choi YL4, Lee JH1, Park K3, Lee KS1.
    View PubMed
  • Head Neck. 2015 May;37(5):E66-9. doi: 10.1002/hed.23884. Epub 2015 Mar 29. Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series Kim SM11, Kim MJ, Jung HA, Sun JM, Choi YL, Ko YH, Park K, Baek CH, Son YI, Ahn MJ.
    View PubMed
  • Ann Dermatol. 2015 Apr;27(2):157-62. doi: 10.5021/ad.2015.27.2.157. Epub 2015 Mar 24. Identification of Leukocyte-Specific Protein 1-Positive Cells: A Clue to the Cell of Origin and a Marker for the Diagnosis of Dermatofibroma Jin SY11, Choi JS2, Choi YL3, Choi YL3, Kim do H1, Lee SH1.
    View PubMed
  • Mod Pathol. 2015 Apr;28(4):468-79. doi: 10.1038/modpathol.2014.107. Epub 2014 Sep 19. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma Lee SE11, Lee B1, Hong M1, Song JY2, Jung K3, Lira ME4, Mao M4, Han J1, Kim J5, Choi YL6.
    View PubMed
  • Pancreas. 2015 Apr;44(3):484-92. doi: 10.1097/MPA.0000000000000280. Low Frequency of KRAS Mutation in Pancreatic Ductal Adenocarcinomas in Korean Patients and Its Prognostic Value Kwon MJ11, Jeon JY, Park HR, Nam ES, Cho SJ, Shin HS, Kwon JH, Kim JS, Han B, Kim DH, Choi YL.
    View PubMed
  • BMC Cancer. 2015 Mar 19;15:154. doi: 10.1186/s12885-015-1160-x. Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series Yoo KH11, Kim HS2, Lee SJ3, Park SH4, Kim SJ5, Kim SH6, La Choi Y7, Shin KH8, Cho YJ9, Lee J10, Rha SY11.
    View PubMed
  • Clin Cancer Res. 2015 Mar 1;21(5):1172-82. doi: 10.1158/1078-0432.CCR-14-1589. Epub 2014 Dec 30. Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy Lee HW11, Lee JI2, Lee SJ3, Cho HJ2, Song HJ4, Jeong da E5, Seo YJ2, Shin S5, Joung JG6, Kwon YJ7, Choi YL8, Park WY9, Lee HM10, Seol HJ2, Shim YM11, Joo KM12, Nam DH13.
    View PubMed
  • Oncotarget. 2015 Mar 10;6(7):5465-74. Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR Ha SY11, Choi SJ2, Cho JH3, Choi HJ2, Lee J2, Jung K4, Irwin D5, Liu X6,7, Lira ME8, Mao M9, Kim HK3, Choi YS3, Shim YM3, Park WY10, Choi YL1,4,10, Kim J2,3.
    View PubMed
  • Oncotarget. 2015 Feb 10;6(4):2562-72. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma Kim HS11, Lee SE2, Bae YS3, Kim DJ4, Lee CG5, Hur J6, Chung H7, Park JC7, Jung da H7, Shin SK7, Lee SK7, Lee YC7, Kim HR1, Moon YW1, Kim JH1, Shim YM8, Jewell SS9, Kim H3, Choi YL2, Cho BC1.
    View PubMed
  • Ann Oncol. 2015 Jan;26(1):161-6. doi: 10.1093/annonc/mdu504. Epub 2014 Oct 29. Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing Sun JM11, Choi YL2, Ji JH3, Ahn JS1, Kim KM2, Han J2, Ahn MJ1, Park K4.
    View PubMed
  • Clin Nucl Med. 2015 Jan;40(1):e34-9. doi: 10.1097/RLU.0000000000000581. Role of Imaging Biomarkers in Predicting Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Jeong CJ11, Lee HY, Han J, Jeong JY, Lee KS, Choi YL, Choi JY.
    View PubMed
  • Mol Cancer Res. 2014 Dec;12(12):1779-95. doi: 10.1158/1541-7786.MCR-14-0191. Epub 2014 Jul 24. SMAD4 Suppresses AURKA-Induced Metastatic Phenotypes via Degradation of AURKA in a TGF beta-Independent Manner Jia L11, Lee HS2, Wu CF1, Kundu J3, Park SG4, Kim RN5, Wang LH1, Erkin ?C6, Choi JS7, Chae SW8, Yang HB2, Choi YL9, Shin YK10.
    View PubMed
  • Exp Mol Pathol. 2014 Dec;97(3):440-4. doi: 10.1016/j.yexmp.2014.09.013. Epub 2014 Oct 1. The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex Yang HM11, Choi HJ1, Hong DP1, Joo SY2, Lee NE2, Song JY3, Choi YL4, Lee J5, Choi D6, Kim B7, Park HJ8, Park JB9, Kim SJ10.
    View PubMed
  • Mol Cancer Ther. 2014 Nov;13(11):2527-36. doi: 10.1158/1535-7163.MCT-14-0255. Epub 2014 Sep 23. Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows Potent In Vitro Antitumor Activity in Gastric Cancer Cell Lines with FGFR2 Amplification Kim ST11, Jang HL2, Lee SJ1, Lee J1, Choi YL3, Kim KM3, Cho J4, Park SH1, Park YS1, Lim HY1, Yashiro M5, Kang WK1, Park JO6.
    View PubMed
  • Genomics. 2014 Oct;104(4):234-41. doi: 10.1016/j.ygeno.2014.07.012. Epub 2014 Jul 25. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing Xie T11, Cho YB2, Wang K3, Huang D4, Hong HK5, Choi YL6, Ko YH7, Nam DH8, Jin J9, Yang H10, Fernandez J11, Deng S12, Rejto PA13, Lee WY14, Mao M15.
    View PubMed
  • Oncotarget. 2014 Oct 15;5(19):9065-78. Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma Hwang JA11, Yang HM2, Hong DP2, Joo SY3, Choi YL4, Park JH5, Lazar AJ6, Pollock RE7, Lev D6, Kim SJ8.
    View PubMed
  • Breast Cancer Res. 2014 Sep 12;16(5):436. doi: 10.1186/s13058-014-0436-4. The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells Bergamaschi A1, Madak-Erdogan Z, Kim YJ, Choi YL, Lu H, Katzenellenbogen BS.
    View PubMed
  • Korean J Radiol. 2014 Sep-Oct;15(5):646-50. doi: 10.3348/kjr.2014.15.5.646. Epub 2014 Sep 12. Synchronous Triple Primary Lung Cancers: A Case Report Yoon HJ11, Lee HY1, Han J2, Choi YL2.
    View PubMed
  • PLoS One. 2014 Aug 14;9(8):e99452. doi: 10.1371/journal.pone.0099452. eCollection 2014. CDK4 Amplification Predicts Recurrence of Well-Differentiated Liposarcoma of the Abdomen Lee S11, Park H1, Ha SY2, Paik KY3, Lee SE2, Kim JM1, Park JB1, Kwon CH1, Joh JW1, Choi YL4, Kim SJ5.
    View PubMed
  • Int J Cancer. 2014 May 15;134(10):2424-36. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer Kim YJ1, Choi JS, Seo J, Song JY, Lee SE, Kwon MJ, Kwon MJ, Kundu J, Jung K, Oh E, Shin YK, Choi YL.
    View PubMed
  • Oncology. 2014;86(3):159-69. doi: 10.1159/000358064. Epub 2014 Mar 12. Low Expression of Transforming Growth Factor Beta-1 in Cancer Tissue Predicts a Poor Prognosis for Patients with Stage III Rectal Cancers Chun HK11, Jung KU, Choi YL, Hong HK, Kim SH, Yun SH, Kim HC, Lee WY, Cho YB.
    View PubMed
  • Skeletal Radiol. 2014 May;43(5):641-8. doi: 10.1007/s00256-014-1832-7. Epub 2014 Feb 15. Prognostic value of F-18-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters Hong SP11, Lee SE, Choi YL, Seo SW, Sung KS, Koo HH, Choi JY.
    View PubMed
  • J Thorac Oncol. 2014 Apr;9(4):563-6. doi: 10.1097/JTO.0000000000000093. A Novel Fusion of TPR and ALK in Lung Adenocarcinoma Choi YL11, Lira ME, Hong M, Kim RN, Choi SJ, Song JY, Pandy K, Mann DL, Stahl JA, Peckham HE, Zheng Z, Han J, Mao M, Kim J.
    View PubMed
  • J Surg Res. 2014 Apr;187(2):502-9. doi: 10.1016/j.jss.2013.11.010. Epub 2013 Nov 15. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors Cho YB11, Hong HK1, Choi YL2, Oh E2, Joo KM3, Jin J4, Nam DH4, Ko YH2, Lee WY5.
    View PubMed
  • J Mol Diagn. 2014 Mar;16(2):229-43. doi: 10.1016/j.jmoldx.2013.11.007. Epub 2014 Jan 10. A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer Lira ME11, Choi YL2, Lim SM3, Deng S1, Huang D1, Ozeck M1, Han J4, Jeong JY5, Shim HS5, Cho BC3, Kim J6, Ahn MJ7, Mao M8.
    View PubMed
  • J Thorac Oncol. 2014 Mar;9(3):419-22. doi: 10.1097/JTO.0000000000000061. HIP1-ALK, a Novel Fusion Protein Identified in Lung Adenocarcinoma Hong M11, Kim RN, Song JY, Choi SJ, Oh E, Lira ME, Mao M, Takeuchi K, Han J, Kim J, Choi YL.
    View PubMed
  • AJR Am J Roentgenol. 2014 Mar;202(3):W224-33. doi: 10.2214/AJR.13.11819. Pure Ground-Glass Opacity Neoplastic Lung Nodules: Histopathology, Imaging, and Management Lee HY11, Choi YL, Lee KS, Han J, Zo JI, Shim YM, Moon JW.
    View PubMed
  • J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28. Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ Lee JH11, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.
    View PubMed
  • Lung Cancer. 2014 Mar;83(3):411-5. doi: 10.1016/j.lungcan.2013.12.015. Epub 2014 Jan 7. Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement Ha SY11, Choi IH1, Han J2, Choi YL1, Cho JH3, Lee KJ4, Sun JM5.
    View PubMed
  • PLoS One. 2014 Feb 26;9(2):e88598. doi: 10.1371/journal.pone.0088598. eCollection 2014. Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy Chong Y11, Kim JH1, Lee HY1, Ahn YC2, Lee KS1, Ahn MJ3, Kim J4, Shim YM4, Han J5, Choi YL5.
    View PubMed
  • Anticancer Res. 2014 Feb;34(2):707-14. Assessment of Intratumoral Heterogeneity of Oncogenic Driver Mutations in Surgically-resected Lung Adenocarcinoma: Implications of Percutaneous Biopsy-based Molecular Assay for Target-directed Therapy Kim HK11, Lee HY, Choi YL, Choi SJ, Choi H, Lee J, Han J, Ahn MJ, Lee KS, Kim J.
    View PubMed
  • PLoS One. 2014 Feb 11;9(2):e88587. doi: 10.1371/journal.pone.0088587. eCollection 2014. Targeted Inhibition of FAK, PYK2 and BCL-XL Synergistically Enhances Apoptosis in Ovarian Clear Cell Carcinoma Cell Lines Yoon H11, Choi YL2, Song JY1, Do I3, Kang SY4, Ko YH5, Song S4, Kim BG6.
    View PubMed
  • Lung Cancer. 2014 Feb;83(2):259-64. doi: 10.1016/j.lungcan.2013.11.009. Epub 2013 Nov 20. Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma Sun JM11, Lira M2, Pandya K2, Choi YL3, Ahn JS1, Mao M2, Han J3, Park K1, Ahn MJ4, Kim J5.
    View PubMed
  • Urol Oncol. 2014 Jan;32(1):49.e23-31. doi: 10.1016/j.urolonc.2013.07.015. FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy Sung JY11, Sun JM2, Chang Jeong B3, Il Seo S3, Soo Jeon S3, Moo Lee H3, Yong Choi H3, Young Kang S4, Choi YL5, Young Kwon G6.
    View PubMed
  • Sci Rep. 2014 Jan 10;4:3623. doi: 10.1038/srep03623. Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling Park S11, Lee J1, Do IG2, Jang J2, Rho K3, Ahn S3, Maruja L4, Kim SJ5, Kim KM2, Mao M4, Oh E6, Kim YJ6, Kim J7, Choi YL2.
    View PubMed
  • Sci Rep. 2014 Jan 10;4:3623. doi: 10.1038/srep03627. Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling Park S11, Lee J1, Do IG2, Jang J2, Rho K3, Ahn S3, Maruja L4, Kim SJ5, Kim KM2, Mao M4, Oh E6, Kim YJ6, Kim J7, Choi YL6.
    View PubMed
  • Eur Spine J. 2014 Jan;23(1):27-31. Synovial sarcoma of the spine: a case involving paraspinal muscle with extensive calcification and the surgical consideration in treatment Kim J1, Lee SH, Choi YL, Bae GE, Kim ES, Eoh W.
    View PubMed
  • Br J Cancer. 2014 Jan 21;110(2):384-91. doi: 10.1038/bjc.2013.757. Epub 2013 Dec 17. Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment Park YH11, Jung HA1, Choi MK1, Chang W1, Choi YL2, Do IG2, Ahn JS1, Im YH1.
    View PubMed
  • J Clin Oncol. 2014 Jan 10;32(2):121-8. doi: 10.1200/JCO.2013.50.8556. Epub 2013 Dec 9. Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients Kim Y11, Hammerman PS, Kim J, Yoon JA, Lee Y, Sun JM, Wilkerson MD, Pedamallu CS, Cibulskis K, Yoo YK, Lawrence MS, Stojanov P, Carter SL, McKenna A, Stewart C, Sivachenko AY, Oh IJ, Kim HK, Choi YS, Kim K, Shim YM, Kim KS, Song SY, Na KJ, Choi YL, Hayes DN, Kim J, Cho S, Kim YC, Ahn JS, Ahn MJ, Getz G, Meyerson M, Park K.
    View PubMed
  • Histol Histopathol. 2014 Jan;29(1):127-38. Epub 2013 Jul 15. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma Lee SE11, Kim YJ2, Kwon MJ3, Choi DI4, Lee J5, Cho J1, Seo SW6, Kim SJ7, Shin YK8, Choi YL9.
    View PubMed
  • Int J Gynecol Cancer. 2013 Nov;23(9):1552-60. doi: 10.1097/01.IGC.0000434105.98035.c7. Establishment of Primary Xenograft Model From Newly Characterized Patient Extrauterine Carcinosarcoma Lee HJ11, Choi HJ, Yang HM, Kim YM, Lee J, Chio D, Kim B, Choi YL, Kim SJ.
    View PubMed
  • Pathol Int. 2013 Oct;63(10):502-5. doi: 10.1111/pin.12097. Epub 2013 Oct 18. Epithelioid hemangioendothelioma with extensive cystic change and CAMTA1 rearrangement Lee SE11, Park HY, Kim S, Bang H, Min JH, Choi YL.
    View PubMed
  • PLoS One. 2013 Jul 29;8(7):e69752. doi: 10.1371/journal.pone.0069752. Print 2013. Genetic Aberrations in Imatinib-Resistant Dermatofibrosarcoma Protuberans Revealed by Whole Genome Sequencing Hong JY11, Liu X, Mao M, Li M, Choi DI, Kang SW, Lee J, La Choi Y.
    View PubMed
  • Hum Pathol. 2013 Jul;44(7):1300-9. doi: 10.1016/j.humpath.2012.09.021. Epub 2013 Jan 22. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications Ha SY11, Lee SE, Kwon MJ, Kim YJ, Lee EH, Seo J, Jang KT, Lee J, Choi YL.
    View PubMed
  • Lung Cancer. 2013 Jul;81(1):109-16. doi: 10.1016/j.lungcan.2013.03.014. Epub 2013 Apr 6. Prognostic significance of CD151 overexpression in non-small cell lung cancer Kwon MJ11, Seo J, Kim YJ, Kwon MJ, Choi JY, Kim TE, Lee DH, Park S, Shin YK, Han J, Choi YL.
    View PubMed
  • J Clin Oncol. 2013 Mar 20;31(9):e132-6. doi: 10.1200/JCO.2012.44.0800. Epub 2013 Jan 28. Angiosarcoma Arising Within a Long-Standing Cystic Lesion of the Adrenal Gland: A Case Report Sung JY11, Ahn S, Kim SJ, Park YS, Choi YL.
    View PubMed
  • PLoS One. 2013;8(2):e56011. doi: 10.1371/journal.pone.0056011. Epub 2013 Feb 28. EGFR Mutation Testing in Patients with Advanced Non-Small Cell Lung Cancer: A Comprehensive Evaluation of Real-World Practice in an East Asian Tertiary Hospital Choi YL11, Sun JM, Cho J, Rampal S, Han J, Parasuraman B, Guallar E, Lee G, Lee J, Shim YM.
    View PubMed
  • Korean J Pathol. 2013 Feb;47(1):77-81. doi: 10.4132/KoreanJPathol.2013.47.1.77. Epub 2013 Feb 25. Peripheral Primitive Neuroectodermal Tumor with Osseous Component of the Small Bowel Mesentery: A Case Study Kim JM11, Chu YC, Choi CH, Kim L, Choi SJ, Park IS, Han JY, Kim KR, Choi YL, Kim T.
    View PubMed
  • Lung Cancer. 2013 Jan;79(1):40-5. doi: 10.1016/j.lungcan.2012.10.002. Epub 2012 Oct 25. Favorable clinical outcomes of pemetrexed treatment in anaplastic lymphoma kinase positive non-small-cell lung cancer Lee HY11, Ahn HK, Jeong JY, Kwon MJ, Han JH, Sun JM, Ahn JS, Park K, Choi YL, Ahn MJ.
    View PubMed
  • J Mol Diagn. 2013 Jan;15(1):51-61. doi: 10.1016/j.jmoldx.2012.08.006. Epub 2012 Dec 12. Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer Lira ME11, Kim TM, Huang D, Deng S, Koh Y, Jang B, Go H, Lee SH, Chung DH, Kim WH, Schoenmakers EF, Choi YL, Park K, Ahn JS, Sun JM, Ahn MJ, Kim DW, Mao M.
    View PubMed
  • Int J Oncol. 2012 Dec;41(6):2013-20. doi: 10.3892/ijo.2012.1663. Epub 2012 Oct 15. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer Lee HW11, Seol HJ, Choi YL, Ju HJ, Joo KM, Ko YH, Lee JI, Nam DH.
    View PubMed
  • Korean J Pathol. 2012 Oct;46(5):436-42. doi: 10.4132/KoreanJPathol.2012.46.5.436. Epub 2012 Oct 25. A Proposal for Creating a Guideline for Cancer Registration of the Fibromatosis, PEComa Group, Malignant Lymphoma In Situ and Dendritic Cell Tumors (III) Yoo C11, Kang CS, Choi YL, Kang HY, Kim JM, Koh YH, Lee JH, Lee SS, Kim IS, Kim DH, Park YK, Sohn JH.
    View PubMed
  • Int J Oncol. 2012 Sep;41(3):839-48. doi: 10.3892/ijo.2012.1517. Epub 2012 Jun 12. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting beta-catenin signaling Kundu J11, Wahab SM, Kundu JK, Choi YL, Erkin OC, Lee HS, Park SG, Shin YK.
    View PubMed
  • Hum Pathol. 2012 Aug;43(8):1234-42. doi: 10.1016/j.humpath.2011.09.012. Epub 2012 Jan 14. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases Lee SE11, Lee EH, Park H, Sung JY, Lee HW, Kang SY, Seo S, Kim BH, Lee H, Seo AN, Ahn G, Choi YL.
    View PubMed
  • Korean J Pathol. 2012 Jun;46(3):306-10. doi: 10.4132/KoreanJPathol.2012.46.3.306. Epub 2012 Jun 22. Extranodal Follicular Dendritic Cell Sarcoma with Rapid Growth in Parapharynx: A Case Report Pyo JS11, Kang G, Do SI, Chae SW, Kim K, Lee SH, Choi YL, Choi JH, Sohn JH, Kim DH.
    View PubMed
  • Brain Pathol. 2012 May;22(3):307-17. doi: 10.1111/j.1750-3639.2011.00532.x. Epub 2011 Nov 14. Mutated IDH1 Is a Favorable Prognostic Factor for Type 2 Gliomatosis Cerebri Kwon MJ11, Kim ST, Kwon MJ, Kong DS, Lee D, Park S, Kang SY, Song JY, Nam DH, Kato Y, Choi YL, Suh YL.
    View PubMed
  • Breast Cancer Res Treat. 2012 Apr;132(2):499-509. doi: 10.1007/s10549-011-1626-8. Epub 2011 Jun 11. A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity Oh E11, Choi YL, Park T, Lee S, Nam SJ, Shin YK.
    View PubMed
  • Korean J Pathol. 2012 Apr;46(2):115-22. doi: 10.4132/KoreanJPathol.2012.46.2.115. Epub 2012 Apr 25. Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience Cho J11, Lee SE, Choi YL.
    View PubMed
  • Int J Cancer. 2012 Apr 15;130(8):1925-36. doi: 10.1002/ijc.26197. Epub 2011 Aug 8. The synergistic therapeutic effect of cisplatin with Human Papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo Jung HS11, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK, Her SW, Ju W, Choi YL, Song SY, Kim JK, Kim YD, Shim GY, Shin YK.
    View PubMed
  • Histol Histopathol. 2012 Feb;27(2):197-207. High MET copy number and MET overexpression: Poor outcome in non-small cell lung cancer patients Park S11, Choi YL, Sung CO, An J, Seo J, Ahn MJ, Ahn JS, Park K, Shin YK, Erkin OC, Song K, Kim J, Shim YM, Han J.
    View PubMed
  • Br J Cancer. 2012 Feb 28;106(5):923-30. doi: 10.1038/bjc.2012.11. Epub 2012 Jan 31. Clinical significance of CD151 overexpression in subtypes of invasive breast cancer Kwon MJ11, Park S, Choi JY, Oh E, Kim YJ, Park YH, Cho EY, Kwon MJ, Nam SJ, Im YH, Shin YK, Choi YL.
    View PubMed
  • Pain Physician. 2012 Jan-Feb;15(1):E107-13. The Neurological Safety of Intrathecal Acyclovir in Rats Kim H11, Choi YL, Lee DK, Choi SS, Lee IO, Kong MH, Kim NS, Lim SH, Lee M.
    View PubMed
  • Histopathology. 2012 Jan;60(2):347-56. doi: 10.1111/j.1365-2559.2011.04072.x. Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast Kim T11, Jung EA, Song JY, Roh JH, Choi JS, Kwon JE, Kang SY, Cho EY, Shin JH, Nam SJ, Yang JH, Choi YL.
    View PubMed
  • Pathol Int. 2012 Jan;62(1):65-8. doi: 10.1111/j.1440-1827.2011.02752.x. Epub 2011 Nov 24. Sclerosing epithelioid fibrosarcoma: Cytogenetic analysis of FUS rearrangement Yoon N11, Kwon JW, Seo SW, Ahn G, Choi YL.
    View PubMed
  • Pathol Res Pract. 2011 Dec 15;207(12):762-8. doi: 10.1016/j.prp.2011.10.002. Epub 2011 Nov 8. Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue Kwon MJ11, Lee SE, Kang SY, Choi YL.
    View PubMed
  • Pathol Res Pract. 2011 Oct 15;207(10):634-9. doi: 10.1016/j.prp.2011.07.011. Epub 2011 Sep 21. Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors Kwon MJ11, Choi YL, Sung KW, Kang SY, Park SM, Choi SY, Kim JS, Suh YL.
    View PubMed
  • Histol Histopathol. 2011 Oct;26(10):1231-41. Detection of Merkel cell polyomavirus in Merkel cell carcinomas and small cell carcinomas by PCR and immunohistochemistry Jung HS11, Choi YL, Choi JS, Roh JH, Pyon JK, Woo KJ, Lee EH, Jang KT, Han J, Park CS, Park YS, Shin YK.
    View PubMed
  • Cancer Chemother Pharmacol. 2011 Sep;68(3):743-51. doi: 10.1007/s00280-010-1545-0. Epub 2010 Dec 18. Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer Lee SJ11, Choi YL, Park YH, Kim ST, Cho EY, Ahn JS, Im YH.
    View PubMed
  • Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation Manifested as a Soft Tissue Mass: Incidental Discovery on Histological Examination
  • PLoS Genet. 2011 Mar;7(3):e1001351. doi: 10.1371/journal.pgen.1001351. Epub 2011 Mar 31. Cancer-Associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis Choi JW11, Kim DG, Lee AE, Kim HR, Lee JY, Kwon NH, Shin YK, Hwang SK, Chang SH, Cho MH, Choi YL, Kim J, Oh SH, Kim B, Kim SY, Jeon HS, Park JY, Kang HP, Park BJ, Han JM, Kim S.
    View PubMed
  • PLoS One. 2011 Feb 24;6(2):e16636. doi: 10.1371/journal.pone.0016636. Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker Lin AY11, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR.
    View PubMed
  • Tumour Biol. 2011 Feb;32(1):45-51. doi: 10.1007/s13277-010-0089-6. Epub 2010 Aug 10. Clinical presentation of carcinoma of unknown primary: 14 years of experience Yi JH11, La Choi Y, Lee SJ, Ahn HK, Baek KK, Lim T, Lee DJ, Han BR, Lee HY, Jun HJ, Lee J, Park YH.
    View PubMed
  • Exp Mol Med. 2011 Feb 28;43(2):91-100. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration Park K11, Chung YJ, So H, Kim K, Park J, Oh M, Jo M, Choi K, Lee EJ, Choi YL, Song SY, Bae DS, Kim BG, Lee JH.
    View PubMed
  • BMC Cancer. 2010 Sep 23;10:507. doi: 10.1186/1471-2407-10-507. Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival (vol 10, pg 507, 2010) Choi YL11, Oh E, Park S, Kim Y, Park YH, Song K, Cho EY, Hong YC, Choi JS, Lee JE, Kim JH, Nam SJ, Im YH, Yang JH, Shin YK.
    View PubMed
  • J Plast Reconstr Aesthet Surg. 2010 Dec;63(12):2064-70. doi: 10.1016/j.bjps.2010.01.020. Epub 2010 Mar 5. Merkel cell carcinoma: Our experience with seven patients in Korea and a literature review Woo KJ11, Choi YL, Jung HS, Jung G, Shin YK, Jang KT, Han J, Pyon JK.
    View PubMed
  • Virchows Arch. 2009 Feb;454(2):203-10. doi: 10.1007/s00428-008-0703-9. Epub 2008 Dec 20. One-step Nucleic Acid Amplification (OSNA): Intraoperative Rapid Molecular Diagnostic Method for the Detection of Sentinel Lymph Node Metastases in Breast Cancer Patients in Korean Cohort Schem C11, Maass N, Bauerschlag DO, Carstensen MH, Loning T, Roder C, Batic O, Jonat W, Tiemann K.
    View PubMed
  • Pathol Int. 2010 Dec;60(12):784-6. doi: 10.1111/j.1440-1827.2010.02599.x. Epub 2010 Sep 24. Dermatofibrosarcoma protuberans of the breast skin Kim T11, Choi YL, Park HY, Song JY, Shin JH, Nam SJ, Ahn G.
    View PubMed
  • BMC Cancer. 2010 Sep 23;10:507. doi: 10.1186/1471-2407-10-507. Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival Choi YL11, Oh E, Park S, Kim Y, Park YH, Song K, Cho EY, Hong YC, Choi JS, Lee JE, Kim JH, Nam SJ, Im YH, Yang JH, Shin YK.
    View PubMed
  • Carcinogenesis. 2010 Jun;31(6):974-83. doi: 10.1093/carcin/bgp336. Epub 2010 Jan 6. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications Kwon MJ11, Kim SS, Choi YL, Jung HS, Balch C, Kim SH, Song YS, Marquez VE, Nephew KP, Shin YK.
    View PubMed
  • The Frequency of BRAF Mutation in Very Small Papillary Thyroid Carcinomas
  • Med Oncol.?2010 Jun;27(2):459-65. doi: 10.1007/s12032-009-9234-8. Epub 2009 May 27. Expression of MET in alveolar soft part sarcoma Jun HJ11,?Lee J,?Lim do H,?Park JO,?Ahn G,?Seo SW,?Sung KS,?Lim do H,?Yoo KH,?Choi YL.
    View PubMed
  • Cancer Res. 2010 Mar 15;70(6):2296-306. doi: 10.1158/0008-5472.CAN-09-3141. Epub 2010 Mar 9. LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer Choi YL11, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, Yang JH, Kao J, Godwin AK, Pollack JR.
    View PubMed
  • Histopathology. 2010 Feb;56(3):408-10. doi: 10.1111/j.1365-2559.2010.03487.x. FOXL2 mutation in granulosa-cell tumours of the ovary Kim T1, Sung CO, Song SY, Bae DS, Choi YL.
    View PubMed
  • Int J Gynecol Pathol. 2009 Nov;28(6):529-34. doi: 10.1097/PGP.0b013e3181a2b8d3. Atypical Leiomyomas of the Uterus With Long-term Follow-up After Myomectomy With Immunohistochemical Analysis for p16(INK4A), p53, Ki-67, Estrogen Receptors, and Progesterone Receptors Sung CO11, Ahn G, Song SY, Choi YL, Bae DS.
    View PubMed
  • Hepatology. 2009 Apr;49(4):1122-31. doi: 10.1002/hep.22740. Liver X Receptor Mediates Hepatitis B Virus X Protein-Induced Lipogenesis in Hepatitis B Virus-Associated Hepatocellular Carcinoma Na TY11, Shin YK, Roh KJ, Kang SA, Hong I, Oh SJ, Seong JK, Park CK, Choi YL, Lee MO.
    View PubMed
  • Breast Cancer Res Treat. 2009 Jan;113(1):83-93. doi: 10.1007/s10549-008-9909-4. Epub 2008 Jan 29. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients Choi YJ11, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS, Kim JH, Yang JH, Nam SJ.
    View PubMed
  • Mol Oncol. 2008 Dec;2(4):327-39. doi: 10.1016/j.molonc.2008.09.004. Epub 2008 Oct 2. CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer Bergamaschi A11, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerød A, Han W, Noh DY, Huntsman DG, Jeffrey SS, Børresen-Dale AL, Pollack JR.
    View PubMed
  • Prostate. 2008 Aug 1;68(11):1248-56. doi: 10.1002/pros.20792. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle Thompson M11, Lapointe J, Choi YL, Ong DE, Higgins JP, Brooks JD, Pollack JR.
    View PubMed
  • Cancer Res. 2008 Aug 15;68(16):6831-9. doi: 10.1158/0008-5472.CAN-07-6195. Centrosomal PKC beta II and pericentrin are critical for human prostate cancer growth and angiogenesis Kim J11, Choi YL, Vallentin A, Hunrichs BS, Hellerstein MK, Peehl DM, Mochly-Rosen D.
    View PubMed
  • Oncogene. 2008 Jun 5;27(25):3635-40. doi: 10.1038/sj.onc.1211012. Epub 2008 Jan 21. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer Kwei KA11, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K, Lee J, Choi YL, Sato M, Wang P, Hernandez-Boussard T, Gazdar AF, Petersen I, Minna JD, Pollack JR.
    View PubMed
  • PLoS Genet. 2008 May 23;4(5):e1000081. doi: 10.1371/journal.pgen.1000081. Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer Kwei KA11, Bashyam MD, Kao J, Ratheesh R, Reddy EC, Kim YH, Montgomery K, Giacomini CP, Choi YL, Chatterjee S, Karikari CA, Salari K, Wang P, Hernandez-Boussard T, Swarnalata G, van de Rijn M, Maitra A, Pollack JR.
    View PubMed
  • Histol Histopathol. 2007 Nov;22(11):1185-95. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation Choi YL11, Kim J, Kwon MJ, Choi JS, Kim TJ, Bae DS, Koh SS, In YH, Park YW, Kim SH, Ahn G, Shin YK.
    View PubMed
  • Clin Cancer Res. 2007 May 1;13(9):2584-91. Clinical significance of CD99 down-regulation in gastric adenocarcinoma Lee JH11, Kim SH, Wang LH, Choi YL, Kim YC, Kim JH, Park TS, Hong YC, Shin YK.
    View PubMed
  • Histol Histopathol. 2007 Mar;22(3):227-34. Expression of TGF-beta signaling proteins in normal placenta and gestational trophoblastic disease Xuan YH11, Choi YL, Shin YK, Ahn GH, Kim KH, Kim WJ, Lee HC, Kim SH.
    View PubMed
  • Arch Pathol Lab Med. 2007 Feb;131(2):275-81. Overexpression of CD24 - Association with invasiveness in urothelial carcinoma of the bladder Choi YL11, Lee SH, Kwon GY, Park CK, Han JJ, Choi JS, Choi HY, Kim SH, Shin YK.
    View PubMed
  • Tumour Biol. 2007;28(6):327-32. doi: 10.1159/000124238. Epub 2008 Apr 4. Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women Choi YL11, Cho EY, Kim JH, Nam SJ, Oh YL, Song SY, Yang JH, Kim DS.
    View PubMed
  • Clin Cancer Res. 2007 Jan 1;13(1):102-10. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression Wang LH11, Kim SH, Lee JH, Choi YL, Kim YC, Park TS, Hong YC, Wu CF, Shin YK.
    View PubMed
  • Int J Gynecol Cancer. 2007 Jan-Feb;17(1):248-53. Increased expression of calpain 6 in uterine sarcomas and carcinosarcomas: an immunohistochemical analysis Lee SJ11, Choi YL, Lee EJ, Kim BG, Bae DS, Ahn GH, Lee JH.
    View PubMed
  • Jpn J Clin Oncol. 2006 Aug;36(8):489-93. Epub 2006 Jun 20. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer Choi YJ11, Yun HR, Yoo KE, Kim JH, Nam SJ, Choi YL, Ko YH, Kim BT, Yang JH.
    View PubMed
  • Mod Pathol. 2006 Aug;19(8):1139-47. Epub 2006 Jun 16. Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions Xuan YH11, Jung HS, Choi YL, Shin YK, Kim HJ, Kim KH, Kim WJ, Lee YJ, Kim SH.
    View PubMed
  • J Korean Med Sci. 2006 Jun;21(3):559-62. Gastric syphilis mimicking adenocarcinoma : A case report Choi YL11, Han JJ, Lee da K, Cho MH, Kwon GY, Ko YH, Park CK, Ahn G.
    View PubMed
  • Mod Pathol. 2006 May;19(5):675-83. Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions Wang LH11, Choi YL, Hua XY, Shin YK, Song YJ, Youn SJ, Yun HY, Park SM, Kim WJ, Kim HJ, Choi JS, Kim SH.
    View PubMed
  • Virchows Arch. 2006 Mar;448(3):331-6. Epub 2005 Nov 29. Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas Choi YL11, Kang SY, Shin YK, Choi JS, Kim SH, Lee SJ, Bae DS, Ahn G.
    View PubMed
  • Clin Neuropathol. 2006 Jan-Feb;25(1):29-36. Malignant lymphoma of the central nervous system: difficult histologic diagnosis after glucocorticoid therapy prior to biopsy Choi YL11, Suh YL, Kim D, Ko YH, Sung CO, Lee JI.
    View PubMed
  • Anesth Analg. 2005 Nov;101(5):1422-6. The neurological safety of epidural gabapentin in rats: A light microscopic examination Choi SS11, Kim YC, Lim YJ, Lee CJ, Lee PB, Lee SC, Sim WS, Choi YL.
    View PubMed
  • J Korean Med Sci. 2005 Oct;20(5):853-9. Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas Choi YL11, Kim MK, Suh JW, Han J, Kim JH, Yang JH, Nam SJ.
    View PubMed
  • J Neurooncol. 2005 May;73(1):19-27. HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors Choi YL11, Kim CJ, Matsuo T, Gaetano C, Falconi R, Suh YL, Kim SH, Shin YK, Park SH, Chi JG, Thiele CJ.
    View PubMed
  • Gynecol Oncol. 2005 May;97(2):379-86. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors Choi YL11, Kim SH, Shin YK, Hong YC, Lee SJ, Kang SY, Ahn G.
    View PubMed
  • Histol Histopathol. 2005 Jan;20(1):59-66. An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions Xuan YH11, Choi YL, Shin YK, Kook MC, Chae SW, Park SM, Chae HB, Kim SH.
    View PubMed
  • Epilepsy Res. 2004 Dec;62(2-3):171-8. Cortical laminar disorganization is correlated with severity of the cortical dysplasia and surgical outcome - experience with 150 cases Choi YL11, Park SH, Chung CK, Suh YL, Chi JG.
    View PubMed
  • J Histochem Cytochem. 2004 May;52(5):591-601. An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions Choi YL11, Xuan YH, Shin YK, Chae SW, Kook MC, Sung RH, Youn SJ, Choi JW, Kim SH.
    View PubMed
  • Anesth Analg. 2003 Dec;97(6):1716-20. The neurotoxicity of epidural hyaluronic acid in rabbits: A light and electron microscopic examination Lim YJ11, Sim WS, Kim YC, Lee SC, Choi YL.
    View PubMed
  • Am J Surg Pathol. 2003 Jul;27(7):919-28. Primary central nervous system lymphoma in Korea - Comparison of B- and T-cell lymphomas Choi JS11, Nam DH, Ko YH, Seo JW, Choi YL, Suh YL, Ree HJ.
    View PubMed
  • FEBS Lett. 2003 Apr 10;540(1-3):217-22. Engagement of CD99 triggers the exocytic transport of ganglioside GM1 and the reorganization of actin cytoskeleton Yoon SS11, Jung KI, Choi YL, Choi EY, Lee IS, Park SH, Kim TJ.
    View PubMed
  • Exp Mol Med. 2002 Dec 31;34(6):411-8. Characterization and epitope mapping of two monoclonal antibodies against human CD99 Gil MC11, Lee MH, Seo JI, Choi YL, Kim MK, Jung KC, Park SH, Kim TJ.
    View PubMed
  • Pathol Int. 2002 May-Jun;52(5-6):358-66. Comparative study of non-functional islet cell tumors and pancreatic solid and papillary neoplasms: Biological behavior and immunohistochemistry Choi YL11, Oh YL, Kim SH, Park CK, Ahn G.
    View PubMed
  • J Korean Med Sci. 2001 Aug;16(4):424-32. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: Association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma Choi YL11, Park SH, Jang JJ, Park CK.
    View PubMed
  • Appl Immunohistochem Mol Morphol. 2001 Jun;9(2):125-9. CD99 immunoreactivity in ependymoma Choi YL11, Chi JG, Suh YL.
    View PubMed
  • Diagn Cytopathol. 2001 Apr;24(4):256-9. Cytologic clue of so-called nodular histiocytic hyperplasia of the pleura Choi YL11, Song SY.
    View PubMed
  • Arch Pathol Lab Med. 2000 Apr;124(4):563-9. Immunoexpression of inhibin alpha subunit, inhibin/activin beta A subunit and CD99 in ovarian tumors Choi YL11, Kim HS, Ahn G.
    View PubMed